Search company, investor...
Ashvattha Therapeutics company logo

Ashvattha Therapeutics

avttx.com

Executives

5

Board of Directors

2

Ashvattha Therapeutics Management Team

5 Team Members

Ashvattha Therapeutics has 5 executives. Ashvattha Therapeutics's current Founder, Chief Technology Officer is Rangaramanujam Kannan.

Name

Work History

Title

Status

Rangaramanujam Kannan

Founder, Chief Technology Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Rangaramanujam Kannan

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder, Chief Technology Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Ashvattha Therapeutics Board of Directors

2 Board of directors

Ashvattha Therapeutics has 2 board of directors, including Jay Zaveri.

Name

Firm

Work History

Other Seats

Jay Zaveri

Jay Zaveri is a partner at Social Capital, a top decile investment firm in Silicon Valley. Jay makes concentrated investments in companies solving forty of the world’s hardest problems by 2045. Key investments include Swarm, Aclima, Syapse, UrbanFootprint, DroneSeed, Saildrone, Relativity, Ashvattha, Journal and Datacoral. Prior to joining Social Capital, Jay has been a successful technology entrepreneur. He co-founded three technology companies, the most recent of which was mobile productivity application CloudOn, which had ten million enterprise users and was acquired by Dropbox in 2014. Jay has built companies, products and platforms that have scaled to millions of active users in consumer, mobile and enterprise software. His love for cartoons and work in the new media tech space has won him 18 awards, including a Hollywood Film Festival for Best Animated Short.

Ashvattha Therapeutics

Scott Platshon

Scott Platshon has been the Chief Operating Officer since January 2021. Mr. Platshon also served as Chief Operating Officer of Panacea Acquisition Corp. and joined EcoR1 in 2015 where he currently serves as a Partner and is responsible for due diligence and analysis of biotechnology companies for value-oriented investment opportunities. Mr. Platshon previously worked at Aquilo Partners, a boutique life sciences investment bank. Mr. Platshon holds a Bachelor of Science in Bioengineering from Stanford University.

Ashvattha Therapeutics

Name

Jay Zaveri

Scott Platshon

Firm

Work History

Jay Zaveri is a partner at Social Capital, a top decile investment firm in Silicon Valley. Jay makes concentrated investments in companies solving forty of the world’s hardest problems by 2045. Key investments include Swarm, Aclima, Syapse, UrbanFootprint, DroneSeed, Saildrone, Relativity, Ashvattha, Journal and Datacoral. Prior to joining Social Capital, Jay has been a successful technology entrepreneur. He co-founded three technology companies, the most recent of which was mobile productivity application CloudOn, which had ten million enterprise users and was acquired by Dropbox in 2014. Jay has built companies, products and platforms that have scaled to millions of active users in consumer, mobile and enterprise software. His love for cartoons and work in the new media tech space has won him 18 awards, including a Hollywood Film Festival for Best Animated Short.

Scott Platshon has been the Chief Operating Officer since January 2021. Mr. Platshon also served as Chief Operating Officer of Panacea Acquisition Corp. and joined EcoR1 in 2015 where he currently serves as a Partner and is responsible for due diligence and analysis of biotechnology companies for value-oriented investment opportunities. Mr. Platshon previously worked at Aquilo Partners, a boutique life sciences investment bank. Mr. Platshon holds a Bachelor of Science in Bioengineering from Stanford University.

Other Seats

Ashvattha Therapeutics

Ashvattha Therapeutics

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.